INVO Bioscience (INVO) Tops Q3 EPS by $1.50
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts INVO Hot Sheet
Join SI Premium – FREE
INVO Bioscience (NASDAQ: INVO) reported Q3 EPS of ($0.70), $1.50 better than the analyst estimate of ($2.20). Revenue for the quarter came in at $970 thousand versus the consensus estimate of $1.82 million.
For earnings history and earnings-related data on INVO Bioscience (INVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley bearish on Coinbase, slashes target on weaker recovery
- Marriott shares rise 3% in premarket trade after raising full-year forecast
- Amazon shares rise after upgrade, sector strength
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
